Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Targeting of aquaporin 4 into lipid rafts and its biological significance.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial.
Production and use of lentivirus to selectively transduce primary oligodendrocyte precursor cells for in vitro myelination assays.
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
[Registries for neurological drugs landscape].
Optic nerve head component analysis enters the clinic: Will multifocal ERG be the next OCT?
Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis.
Anodal tDCS increases corticospinal output and projection strength in multiple sclerosis.
Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.
Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
What is new in MS spasticity research? Poster session highlights.
Chondroitin sulfate β-1,4-N-acetylgalactosaminyltransferase-1 (ChGN-1) polymorphism: Association with progression of multiple sclerosis.
Longitudinal Evaluation of Visual Function in Multiple Sclerosis.
Subgroup analysis in MS trials.
Natalizumab in the treatment of pediatric multiple sclerosis.
Acute demyelinating encephalomyelitis in a child following malaria.
Usability and Potential of Geostatistics for Spatial Discrimination of Multiple Sclerosis Lesion Patterns.
Oligodendroglia and neurotrophic factors in neurodegeneration.
Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.
The clinical relevance of force platform measures in multiple sclerosis: a review.
Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis.
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation.
Pages
« first
‹ previous
…
351
352
353
354
355
356
357
358
359
…
next ›
last »